首頁 > 市場調查報告書 > 製藥

消化器

市場調查報告書

商品編碼

1567271

胃腸病學市場：依藥物類型、劑型、疾病類型、通路、地區分類

Gastroenterology Market, By Drug Type, By Dosage Form, By Disease Type, By Distribution Channel, By Geography

出版日期: 2024年09月09日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球胃腸病學市場預計到2024年將達到351.2億美元，預計到2031年將達到531億美元，2024年至2031年的複合年成長率為6.1%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	351.2億美元
實際資料	2019-2023	預測期	2024年至2031年
預測 2024-2031 年複合年成長率：	6.10%	2031年價值預測	531億美元

圖：2024 年按地區分類的胃腸病學市場佔有率(%)

全球胃腸病學市場的成長是由胃潰瘍、發炎性腸道疾病腸道疾病和大腸激躁症等胃腸道疾病的增加以及需要有效診斷和治療解決方案的老年人口的增加所推動的。此外，胃腸內視鏡設備的技術進步和胃腸疾病新藥的市場開拓也將支持市場成長。各個市場參與者正在推出新產品並擴大業務，以滿足醫療機構和患者不斷成長的需求。先進胃腸道醫療設備的高昂成本以及低收入國家缺乏認知可能對讓患者更廣泛地獲得醫療保健構成挑戰。

市場動態：

全球胃腸病學市場的成長是由全球胃腸道疾病盛行率增加、易患胃腸道疾病的老年人口增加以及胃腸道醫療設備的進步等因素所推動的。然而，胃腸儀器和內視鏡設備的高成本可能會阻礙市場成長。針對胃腸道問題的新型口服藥物的出現以及新興市場醫療保健基礎設施的開拓可以為市場擴張提供機會。北美因其龐大的患者群體、創新治療方法的快速核准以及市場參與企業的戰略舉措而在全球胃腸病學市場中佔據主導地位。然而，由於中國和印度等國家獲得專業醫療保健的機會有所改善，預計亞太地區將出現更高的成長。

（本次調查的主要特點）

該報告對全球胃腸病學市場進行了詳細分析，並以 2023 年為基準年估計了預測期內（2024-2031 年）的市場規模（十億美元）和年複合成長率（CAGR%）。

它還揭示了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。

它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球胃腸病學市場的主要企業。

本研究涉及的主要企業包括美敦力、強生、雅培、羅氏、拜耳、葛蘭素史克、賽諾菲、輝瑞和諾華。

該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。

胃腸病學市場的全球市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

透過用於分析全球胃腸病學市場的各種策略矩陣，將有助於相關人員做出決策。

公司簡介
- Allied Digestive Health
- Boston Scientific
- Capital Digestive Care
- CRH Medical
- Iterative Scopes
- Fujifilm Medical
- Gastro Health
- GI Alliance
- Medtronic
- Micro-Tech Endoscopy
- Motus GI
- Olympus
- One GI
- PE GI Solutions
- Peak Gastroenterology Associates
- Pentax Medical
- Pinnacle GI Partners
- Saneso
- Surgical Innovations
- Wision AI

第11章分析師建議

命運之輪
分析師觀點
一致的機會圖

第12章調查方法

參考
調查方法

簡介目錄

Product Code: CMI7416

Global gastroenterology market is estimated to be valued at USD 35.12 Bn in 2024 and is expected to reach USD 53.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.1% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 35.12 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	6.10%	2031 Value Projection:	US$ 53.10 Bn

Figure. Gastroenterology Market Share (%), By Region, 2024

Global gastroenterology market growth is driven by rising gastrointestinal disorders such as stomach ulcer, inflammatory bowel disease, irritable bowel syndrome and growing geriatric population that requires effective diagnosis and treatment solutions. Furthermore, technological advancements in gastrointestinal endoscopy devices along with development of novel drugs for gastrointestinal issues can also drive the market growth. Various market players are engaged in new product launches and expansions to cater to increasing needs of healthcare facilities as well as patients. High costs associated with advanced gastroenterology devices and lack of awareness in low-income nations can pose challenges for broader patient access to care.

Market Dynamics:

Global gastroenterology market growth is driven by factors like growing prevalence of gastrointestinal disorders worldwide, increasing geriatric population susceptible to digestive diseases, and advancements in gastrointestinal medical devices. However, high costs associated with gastrointestinal instrumentation and endoscopy devices can hamper the market growth. Emergence of novel oral medicines for gastrointestinal issues and developing healthcare infrastructure in emerging nations can present lucrative opportunities for market expansion. North America dominates the global gasteroenterology market, owing to sizable patient population, fast approval of innovative therapies, and strategic initiatives by market players. However, Asia Pacific is expected to offer high growth prospects due to improving access to specialty care in nations like China and India.

(Key features of the study):

This report provides in-depth analysis of the global gastroenterology market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global gastroenterology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Medtronic, Johnson & Johnson, Abbott Laboratories, Hoffmann-La Roche, Bayer AG, GlaxoSmithKline, Sanofi, Pfizer, and Novartis AG

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global gastroenterology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gastroenterology market

Detailed Segmentation-

By Drug Type Insights (Revenue, USD Bn, 2019 - 2031)
- Biologics/Biosimilars
- Antacids
- Laxatives
- Antidiarrheal Agents
- Antiemetics
- Antiulcer Agents
- Others
By Dosage Form Insights (Revenue, USD Bn, 2019 - 2031)
- Oral
- Parenteral
- Others
By Disease Type Insights (Revenue, USD Bn, 2019 - 2031)
- Inflammatory Bowel Diseases (IBD)
- Crohn's Disease
- Ulcerative Colitis
- Irritable Bowel Syndrome (IBS)
- Gastroesophageal Reflux Disease (GERD)
- Liver Diseases
- Colorectal Cancer
- Others (Peptic Ulcers, etc.)
By Distribution Channel Insights (Revenue, USD Bn, 2019 - 2031)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Allied Digestive Health
- Boston Scientific
- Capital Digestive Care
- CRH Medical
- Iterative Scopes
- Fujifilm Medical
- Gastro Health
- GI Alliance
- Medtronic
- Micro-Tech Endoscopy
- Motus GI
- Olympus
- One GI
- PE GI Solutions
- Peak Gastroenterology Associates
- Pentax Medical
- Pinnacle GI Partners
- Saneso
- Surgical Innovations
- Wision A.I.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Dosage Form
- Market Snapshot, By Disease Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Gastroenterology Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Gastroenterology Market, By Drug Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Biologics/Biosimilars
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Antacids
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Laxatives
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Antidiarrheal Agents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Antiemetics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Antiulcer Agents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Gastroenterology Market, By Dosage Form, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Parenteral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Gastroenterology Market, By Disease Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Inflammatory Bowel Diseases (IBD)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Crohn's Disease
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Ulcerative Colitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Irritable Bowel Syndrome (IBS)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Gastroesophageal Reflux Disease (GERD
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Liver Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Colorectal Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others (Peptic Ulcers, etc.)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Gastroenterology Market, By Distribution Channel, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global Gastroenterology Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
Africa

10. Competitive Landscape

Company Profiles
- Allied Digestive Health
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Boston Scientific
- Capital Digestive Care
- CRH Medical
- Iterative Scopes
- Fujifilm Medical
- Gastro Health
- GI Alliance
- Medtronic
- Micro-Tech Endoscopy
- Motus GI
- Olympus
- One GI
- PE GI Solutions
- Peak Gastroenterology Associates
- Pentax Medical
- Pinnacle GI Partners
- Saneso
- Surgical Innovations
- Wision A.I.